In our study, we proved that METTL3 is highly expressed in CCA, METTL3 knockdown inhibits glycolysis and the malignant phenotype of CCA cells, and the same conclusion also holds for the METTL3 target gene AKR1B10. The gene discussed is METTL3; the disease is cholangiocarcinoma.